Broomfield-based Quantinuum has signed a Memorandum of Understanding (MoU) with the National Quantum Office (NQO) of Singapore, Agency for Science, Technology and Research (A*STAR), National University of Singapore (NUS) and National Supercomputing Centre (NSCC). This agreement allows access to Quantinuum’s advanced quantum computer and aims to explore and collaborate on quantum computing use cases, especially in computational biology.
Under the MoU, the parties will leverage Quantinuum’s H-Series and Helios quantum computers to promote joint research and development in various quantum computing applications. Helios is described as Quantinuum’s next-generation quantum processor that could exponentially increase computing power. The collaboration will also focus on developing hybrid computing solutions combining classical and quantum infrastructures and creating strategic roadmaps.
The MoU also includes initiatives for training and outreach through seminars, workshops and bespoke programs to nurture quantum talent, contributing to Singapore’s growing quantum community.
Singapore, with a strong background in computational biology, will use this MoU to enable scientists from A*STAR’s Bioinformatics Institute (A*STAR’s BII), the Centre for Quantum Technologies (CQT) at NUS, and Duke-NUS Medical School’s Centre for Computational Biology to enhance capabilities in modeling complex biological systems, advancing drug discovery, and personalized medicine.
Additionally, Quantinuum plans to establish a dedicated R&D presence in Singapore to facilitate better knowledge exchange between researchers from both entities. Quantinuum, known for building high-performing quantum computers, offers an integrated, end-to-end quantum computing platform using trapped-ion technology, applicable in fields like pharmaceuticals, material sciences, and finance.
“Our collaboration underscores our commitment to advancing global quantum computing,” stated Rajeeb (Raj) Hazra, CEO of Quantinuum. “By harnessing our cutting-edge H-Series quantum computers and leading quantum application software stack, we aim to pioneer transformative use cases in computational biology and life sciences, catalyzing innovation across industries. Establishing an R&D hub in Singapore enhances our dedication to fostering a vibrant quantum ecosystem, driving scientific excellence, and nurturing top quantum talent. Together, we aim to make significant strides in quantum technologies, supporting Singapore’s ambition to lead in the rapidly evolving technological landscape.”